ArrowMark Colorado Holdings’s Insmed INSM Stock Holding History

ArrowMark Colorado Holdings’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-30,000	Closed	-$3.02M	–	314
2025 Q2	$3.02M	Hold	30,000	–	–	0.05%	214
2025 Q1	$2.29M	Hold	30,000	–	–	0.04%	223
2024 Q4	$2.07M	Hold	30,000	–	–	0.03%	231
2024 Q3	$2.19M	Hold	30,000	–	–	0.03%	225
2024 Q2	$2.01M	Buy	+30,000	New	+$1.16M	0.02%	240
2016 Q4	–	Sell	-4,956	Closed	-$72K	–	368
2016 Q3	$72K	Buy	+4,956	New	+$62K	﹤0.01%	292

Other funds holding INSM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

ArrowMark Colorado Holdings's INSM Position: Q3 2025 in Review

ArrowMark Colorado Holdings sold out of Insmed (INSM) in Q3 2025, closing a stake of 30,000 shares — an estimated $3.02M sold.

ArrowMark Colorado Holdings first reported a position in INSM in Q3 2016 and held it in 6 quarters. The position peaked at $3.02M in Q2 2025. 566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

ArrowMark Colorado Holdings reported no remaining Insmed position as of Q3 2025 after selling out during the quarter.
ArrowMark Colorado Holdings sold 30,000 Insmed shares in Q3 2025, an estimated $3.02M.
ArrowMark Colorado Holdings first reported a position in Insmed in Q3 2016 and held it in 6 quarters.
ArrowMark Colorado Holdings's Insmed position peaked at $3.02M in Q2 2025.
566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.